We have located links that may give you full text access.
Comparative Study
Journal Article
Source apportionment for fine particulate matter in a Chinese city using an improved gas-constrained method and comparison with multiple receptor models.
Environmental Pollution 2018 Februrary
PM2.5 is one of the most studied atmospheric pollutants due to its adverse impacts on human health and welfare and the environment. An improved model (the chemical mass balance gas constraint-Iteration: CMBGC-Iteration) is proposed and applied to identify source categories and estimate source contributions of PM2.5. The CMBGC-Iteration model uses the ratio of gases to PM as constraints and considers the uncertainties of source profiles and receptor datasets, which is crucial information for source apportionment. To apply this model, samples of PM2.5 were collected at Tianjin, a megacity in northern China. The ambient PM2.5 dataset, source information, and gas-to-particle ratios (such as SO2 /PM2.5 , CO/PM2.5 , and NOx/PM2.5 ratios) were introduced into the CMBGC-Iteration to identify the potential sources and their contributions. Six source categories were identified by this model and the order based on their contributions to PM2.5 was as follows: secondary sources (30%), crustal dust (25%), vehicle exhaust (16%), coal combustion (13%), SOC (7.6%), and cement dust (0.40%). In addition, the same dataset was also calculated by other receptor models (CMB, CMB-Iteration, CMB-GC, PMF, WALSPMF, and NCAPCA), and the results obtained were compared. Ensemble-average source impacts were calculated based on the seven source apportionment results: contributions of secondary sources (28%), crustal dust (20%), coal combustion (18%), vehicle exhaust (17%), SOC (11%), and cement dust (1.3%). The similar results of CMBGC-Iteration and ensemble method indicated that CMBGC-Iteration can produce relatively appropriate results.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app